|
|
|
|
LEADER |
01540nam a2200229 u 4500 |
001 |
EB002072008 |
003 |
EBX01000000000000001212098 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
220923 r ||| eng |
100 |
1 |
|
|a Vrolijk, J. J.
|
245 |
0 |
0 |
|a Dutch breast implant registry (DBIR) annual report 2019
|h Elektronische Ressource
|c J.J. Vrolijk
|
246 |
3 |
1 |
|a Annual report DBIR 2019
|
250 |
|
|
|a Version 2020.01
|
260 |
|
|
|a Leiden
|b Dutch Institute for Clinical Auditing
|c 2020, October 2020
|
300 |
|
|
|a 1 PDF file (61 pages)
|b illustrations
|
710 |
2 |
|
|a Dutch Institute for Clinical Auditing
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK568422
|3 Volltext
|
082 |
0 |
|
|a 580
|
520 |
|
|
|a Since April 2015, the Dutch Breast Implant Registry (DBIR) has registered characteristics of patients, surgical procedures, and breast implants to monitor, benchmark, and improve the quality of breast implant surgery in the Netherlands. Additionally, DBIR can be used as a track and trace system for recall purposes.Healthcare providers can gain insight into their quality of care and complications by anonymously comparing results of their clinic to other centers in the Netherlands (i.e., benchmarking). In this way, the provided care can be evaluated, and points of improvement identified. Every year a selection of quality indicators is published on the Transparency Calendar, making this information publicly available
|